"My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South)
Refinement and Pilot Testing of the "My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions in the Deep South (MyHP-South)
The goal of this clinical trial is to evaluate the feasibility and acceptability of the revised My Health Priorities (MyHP) program among rural and underserved older adults with multiple chronic conditions in the Deep South. The program is designed to help participants clarify their health-related values, as well as improve communication with family caregivers and healthcare providers to support medical decision-making. The main question this study aims to answer is whether the revised MyHP program is practical/easy for individuals to use, and if it helps support necessary conversations about healthcare priorities. Participants will be asked to complete the revised MyHP program over a Zoom or in-person session with their caregiver, as well as complete questionnaires over a telephone interview before and 12 weeks after the completion of the program. In addition to participating in the MyHP program, caregivers will also be asked to complete a series of questionnaires over a telephone interview before and 12 weeks after the program. Both patients and caregivers will also be asked to complete a brief survey about their experience with the program over a telephone interview.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Alexis M Johnson, B.S.
- Número de teléfono: 205-975-1864
- Correo electrónico: amjohns2@uab.edu
Copia de seguridad de contactos de estudio
- Nombre: Deborah B Ejem, Ph.D.
- Número de teléfono: 205-996-1671
- Correo electrónico: tejem@uab.edu
Ubicaciones de estudio
-
-
Alabama
-
Birmingham, Alabama, Estados Unidos, 35233
- The Whitaker Clinic of the University of Alabama at Birmingham (UAB) Hospital
-
Contacto:
- Alexis M Johnson, B.S.
- Número de teléfono: 205-975-1864
- Correo electrónico: amjohns2@uab.edu
-
Contacto:
- Deborah B Ejem, Ph.D.
- Número de teléfono: 205-996-1671
- Correo electrónico: tejem@uab.edu
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria for Patients:
- Identifies as African American or White/Caucasian
- Is 65 years of age or older
- Has at least two of the following chronic conditions: cancer, heart disease, kidney disease, liver disease, or lung disease
- English-speaking and able to complete baseline study measures
- Cognitively able to participate in decision-making discussions
- Has a family caregiver that meets the eligibility requirements
- Has reliable telephone access
Inclusion Criteria for Caregivers:
- Identifies as African American or White/Caucasian
- Is 18 years of age or older
- A relative, partner, or friend who provides unpaid assistance or support with health-related decision-making (may or may not live in the same residence)
- English-speaking and able to complete baseline study measures
- Cognitively able to participate in decision-making discussions
- Has reliable telephone access
Exclusion Criteria for Patients:
- Has a documented diagnosis of dementia
- Is unable to understand the study and provide informed consent
- Resides in a nursing home or assisted living facility
Exclusion Criteria for Caregivers:
- Is unable to understand the study and provide informed consent
- Is unable to communicate with research staff
- Is unable to participate in the dyadic MyHP-South session and required assessments
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: MyHP-South Users
Includes the patients and caregivers who will be utilizing the MyHP-South program, as well as evaluating its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. This arm also includes the clinicians who will be assessing the usefulness of the program in a primary care setting. |
Participants will use the refined My Health Priorities South (MyHP-South) program to help identify and communicate personal health priorities, then evaluate its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Patient System Usability Scale (SUS)
Periodo de tiempo: At the MyHP-South session, within 14 days after baseline.
|
Over a Zoom or telephone interview, patients will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree. |
At the MyHP-South session, within 14 days after baseline.
|
|
Acceptability Interview
Periodo de tiempo: At the MyHP-South session, within 14 days after baseline.
|
Over a Zoom or telephone interview, both patients and caregivers will together answer 26 questions regarding their experience using the revised MyHP-South tool. Answer options will be open-ended. |
At the MyHP-South session, within 14 days after baseline.
|
|
Recruitment Feasibility
Periodo de tiempo: From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
|
Indicated by the number and proportion of eligible patient-caregiver dyads who enroll. |
From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
|
|
Retention and Completion Feasibility
Periodo de tiempo: From baseline through 12 weeks after the MyHP-South session.
|
Indicated by the number and proportion of enrolled dyads completing baseline assessments, the MyHP-South session, immediate post-session assessments, the acceptability interview, and the 12-week assessments. |
From baseline through 12 weeks after the MyHP-South session.
|
|
Caregiver System Usability Scale (SUS)
Periodo de tiempo: Immediately after the MyHP-South session, during the same study visit.
|
Over a Zoom or telephone interview, caregivers will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree. |
Immediately after the MyHP-South session, during the same study visit.
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
CollaboRATE Scale Score
Periodo de tiempo: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer three questions regarding their experience with their healthcare provider during a clinical encounter. Answer options will follow a ranked scale ranging from zero to nine and will then be calculated into a final score/percentage. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Treatment Burden Questionnaire (TBQ) Score
Periodo de tiempo: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer 13 questions regarding the potential burden of managing multiple chronic conditions. Answer options will follow a ranked scale ranging from zero to ten and will then be calculated into a final score. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Patient Shared Care Instrument Score
Periodo de tiempo: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer 19 questions regarding communication, decision making, and reciprocity with their caregiver. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Bakas Caregiver Outcomes Scale (BCOS)
Periodo de tiempo: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, caregivers will answer 10 questions regarding potential life changes that have occurred as a result of serving as a caregiver. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from -3: changed for the worse, to +3: changed for the best. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Older Patient Assessment of Chronic Illness Care (O-PACIC) Scale Score
Periodo de tiempo: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer ten questions regarding the quality of medical care they have received over the past six months. Answer options will follow a Likert-type frequency scale, which will then be calculated into a final score. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Caregiver Shared Care Instrument Score
Periodo de tiempo: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, caregivers will answer 19 questions regarding communication, decision making, and reciprocity with their patient. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales. |
At baseline and 12 weeks after the MyHP-South session.
|
Otras medidas de resultado
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Timing Log for MyHP-South Session
Periodo de tiempo: At the MyHP-South session, within 14 days after baseline.
|
Research staff will document the length of each MyHP-South session by documenting what time the session started and what time the session ended. Time used to navigate technical difficulties will be subtracted. Tracking how long the session takes serves as a measure of feasibility. |
At the MyHP-South session, within 14 days after baseline.
|
|
Clinician Feedback Survey
Periodo de tiempo: Within 6 months after the completion of the MyHP-South session.
|
Over an electronic survey, clinicians who provide care to enrolled patients will answer ten questions regarding the clarity, fit, and usefulness of the revised MyHP-South in a primary care setting. |
Within 6 months after the completion of the MyHP-South session.
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Investigador principal: Deborah B Ejem, Ph.D., University of Alabama at Birmingham
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- IRB-300016725
- U54AG093230 (Subvención/contrato del NIH de EE. UU.)
- 606877 (Otro identificador: ASSIST Study ID)
- DGCG-11797 (Otro identificador: NIA CROMS Study ID)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .